Enough Of Wasting Away From Cancer: Companies Gear Up To Tackle Cachexia
Pharma News for Sarepta and Ionis
Bristol-Myers Squibb’s Opdivo & ...

Bristol-Myers Squibb’s Opdivo and Yervoy Combo Fails in Phase III Trial Bristol-Myers Squibb has reported t...

Latest Pharma News for VistaGen and Merck
VistaGen’s PH94B for Anxiety Disorder...

FDA Approves Incyte’s Opzelura as First Vitiligo Therapy The US Food and Drug Administration has approved I...

Latest MedTech News for Centinel and DyAnsys
FDA Approval to Centinel’s Total Disc...

Orthox Obtains MHRA Approval to Commence FFLEX Study  On July 14, 2022, Orthodox Ltd, a clinical-stage...

Latest Pharma News AbbVie and Byondis
Byondis’s HER2-targeting ADC trastuzumab duocarmazine; AbbVie Migraine Drug Atogepant; Grünenthal...

Byondis Files its HER2-Targeting Antibody-Drug Conjugate (ADC) Trastuzumab Duocarmazine in the US and Europe Byondis has filed for clearance of its HER2-targeting antibody-drug conjugate (ADC) ...


MedTech News Updates for Renovia and Zsquare
Zsquare ENT-Flex Rhinolaryngoscope Receives FDA Clearance; ClearMind Biomedical’s Completio...

Zsquare ENT-Flex™ Rhinolaryngoscope, the First High-Performance Single-Use ENT Endoscope of Zsquare received FDA Clearance On July 06, 2022, Zsquare, one of the leading developers of hig...


Pharma News for AbbVie and Sobi
Novo Nordisk’s Concizumab for Hemophilia; AbbVie Ends its Alliance with Alector; ADC Therapeutics...

Novo Nordisk Reports Phase III Results of Concizumab Drug for Hemophilia A or B Novo Nordisk has announced Phase III results for their concizumab drug for hemophilia A or B, demonstrating effic...


vaccines-market-outlook
Comprehensive Assessment of the Leading Companies in the Vaccines Market

Millions of lives are saved annually all because of vaccination, which is a success story in global health and development. More than 20 life-threatening diseases can now be prevented with vaccine...


MedTech News for Terumo, Roche and Insightec
Collagen Matrix FDA 510(k) approval for Fibrillar Collagen Wound Dressing; Roche’s cancer diagnos...

Collagen Matrix received FDA 510(k) approval for Fibrillar Collagen Wound Dressing On June 29, 2022, Collagen Matrix, Inc., a leader in regenerative medicine, a global manufacturer of collagen ...


Pharma News for Sanofi, Bayer, Spero
AstraZeneca’s Imfinzi Shows Positive Results; Novartis Announces Results of Tislelizumab; FDA Gra...

FDA Grants Orphan Drug Designation to Evorpacept for AML ALX Oncology Holdings announced that the U.S. Food and Drug Administration had granted orphan drug designation to Evorpacept, a next-gen...


Gene Therapies Whitepaper
Gene Therapies

Gene therapies are regarded as one of the potential revolution in the Pharmaceutical field and Healt.....

Toll-like Receptors Agonist
Toll-like Receptors Agoni...

Toll-like Receptors (TLRs) are a type of pattern recognition receptor (PRR) that recognizes pathogen.....

Acute Myeloid Leukemia Newsletter
Acute Myeloid Leukemia...

Acute myeloid leukemia (AML), also called acute myelogenous leukemia and acute nonlymphocytic leukem.....

Editor's Pick
Can denovoSkin Be A Lifesaver for Burn Victims?

Burn is a global public health problem, causing more than 180,000 deaths per year acros...

NexoBrid and its Awaiting US Approval

A Burn takes place when the skin comes into contact with a heat source. Burns can occur...

New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Do...

Pulmonary arterial hypertension is a progressive disease of the lung vascular system, p...

Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...

The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...

Emerging Market for Organ on a Chip

The organ on a chip is a microfluidic culture device that recapitulates the complicated...